Position in DHR
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$228,956
+$3,901 QoQ
Shares Held
1,202
+1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,707
of 2,098 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Purkiss Capital Advisors LLC holds $2,716,202 across 2 Diagnostics & Research names. DHR ranks #2 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
4,961 | $2,487,246 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
1,202 | $228,956 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $228,956 | 1,202 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $225,055 | 1,187 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $295,993 | 1,293 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $263,091 | 1,327 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $252,258 | 1,277 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $205,000 | 1,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $229,550 | 1,000 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||